ETON•benzinga•
Eton Pharma Submits NDA To FDA For Proprietary Desmopressin Oral Solution ET-600; Anticipates Q1 2026 Launch After 10-month Review
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2025 by benzinga